Colospan Overview

Colospan is a clinical-stage medical device company developing proprietary technology for colorectal surgery to prevent anastomotic leaks and divert colonic stomas. The companys lead product is a single-use, temporary intraluminal bypass device designed to reduce contact between fecal matter and the anastomotic site.

Cumulative Funding Raised Over Time ($)

Employees Over Time

שיתוף פעולה מנצח בין בלכמן מנס וקולוספן בתחום הביוטק

#Partners #Expand

Colospan receives €8.2 million from the European Innovation Council for its novel colorectal surgery device

#Investment

Colospan accelerates FDA pivotal trial and appoints medtech veteran, Gregory D. Casciaro, to the Board of Directors

#Management Changes

Henry Ford Hospital First in the U.S. to Test Novel CG-100 Intraluminal Device in patients undergoing colorectal anastomosis

#Partners #Customers

Gastrointestinal Bypass Device Offers an Alternative to Diverting Stoma

#Customers

Companies you might be interested in

Driven by Finder AI

Anchora Medical
Minimally Invasive Suturing Device

1-10 employees • Funding Stage: A

shared sectors

Medical Treatment & Therapeutics

Also shared

medical-devices gastroenterology colonoscopy hospitals surgery surgeons surgical-instruments

Are these companies similar?
ValCare Medical
Minimally Invasive Treatment for Valve Disease

11-50 employees • Funding Stage: Seed

shared sectors

Medical Treatment & Therapeutics

Also shared

medical-devices treatments hospitals surgery surgeons

Are these companies similar?
Endomatic
Endovascular Left Atrial Appendage Closure Device

1-10 employees • Funding Stage: Seed

shared sectors

Medical Treatment & Therapeutics

Also shared

medical-devices

Are these companies similar?
GerdCare Medical
First-Ever Noninvasive and Drug Free Technology to Treat Gastroesophageal Reflux Disease (GERD)

1-10 employees • Funding Stage: A

shared sectors

Medical Treatment & Therapeutics

Also shared

medical-devices gastroenterology treatments

Are these companies similar?